Back

dr. F.Y.F.L. (Filip) de Vos

dr. F.Y.F.L. (Filip) de Vos

Assistant Professor - medical
dr. F.Y.F.L. (Filip) de Vos
  • Department of Medical Oncology

Research Programs

Strategic Program Cancer

Biography

Biography

 

Education

 

1993 –   1996

 

1996 –   2000

 

2004

 

 

 

2010

 

 

 

 

Pre-MedicalSchool at Limburg   UniversityCenter,   Hasselt, Belgium 

 

MedicalSchool at University   of Antwerp, Antwerp, Belgium (MD)

 

PhD thesis: “Balance between desired and unwanted effects   of chemotherapeutic and anti-angiogenic drugs” at department of   Medical Oncology at the University    of Groningen, The   Netherlands

 

Degree: Medical Oncologist, University   of Rotterdam, The Netherlands

 

Additional training

 

2013

 

 

 

2013

 

 

2014

 

 

12th Masterclass in Clinical   Oncology by the European School of

Oncology (ESO) and European   Society of Medical Oncology

(ESMO)

 

Clinical   Trial Statistics for Non-Statisticians by the European

Organization   for Research and Treatment in Cancer (EORTC)

 

Basic   Course Legislation and Organization for Clinical Researchers

(BROK)

 

 

Professional  experience

 

2008 – 2010

 

 

2010 – 2011

 

 

2011 –   present

 

 

 

Fellow, Dept of Medical Oncology, ErasmusMedical   Center, Rotterdam,   The Netherlands

 

Staff member, Dept of Medical Oncology, Radboud   University Nijmegen Medical Centre, Nijmegen,   The Netherlands

 

Staff member, Dept of Medical Oncology, University of Utrecht,   Utrecht, the Netherlands

 

Since start of PhD thesis   extensive experience with clinical trials

 

 

Research Output (81)

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Stein Eytan M, DeAngelo Daniel J, Chromik Jörg, Chatterjee Manik, Bauer Sebastian, Lin Chia-Chi, Suarez Cristina, De Vos Filip, Steeghs Neeltje, Cassier Phillippe A, Tai David, Kiladjian Jean-Jacques, Yamamoto Noboru, Mous Rogier, Esteve Jordi, Minami Hironobu, Ferretti Stéphane, Guerreiro Nelson, Meille Christophe, Radhakrishnan Rajkumar, Pereira Bernard, Mariconti Luisa, Halilovic Ensar, Fabre Claire, Carpio Cecilia 3 Dec 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28 , p. 870-881 12 p.

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre, open-label, single-arm, phase 2, basket trial

Wen Patrick Y, Stein Alexander, van den Bent Martin, De Greve Jacques, Wick Antje, de Vos Filip Y F L, von Bubnoff Nikolas, van Linde Myra E, Lai Albert, Prager Gerald W, Campone Mario, Fasolo Angelica, Lopez-Martin Jose A, Kim Tae Min, Mason Warren P, Hofheinz Ralf-Dieter, Blay Jean-Yves, Cho Daniel C, Gazzah Anas, Pouessel Damien, Yachnin Jeffrey, Boran Aislyn, Burgess Paul, Ilankumaran Palanichamy, Gasal Eduard, Subbiah Vivek 24 Nov 2021, In: LANCET ONCOLOGY. 23 , p. 53-64 12 p.

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma

van Kessel Emma, Schuit Ewoud, Huenges Wajer Irene M C, Ruis Carla, De Vos Filip Y F L, Verhoeff Joost J C, Seute Tatjana, van Zandvoort Martine J E, Robe Pierre A, Snijders Tom J 18 Nov 2021, In: Frontiers in Neurology. 12 , p. 1-11

The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis

Hoogstrate Youri, Ghisai Santoesha A, de Wit Maurice, de Heer Iris, Draaisma Kaspar, van Riet Job, van de Werken Harmen J G, Bours Vincent, Buter Jan, Vanden Bempt Isabelle, Eoli Marica, Franceschi Enrico, Frenel Jean-Sebastien, Gorlia Thierry, Hanse Monique C, Hoeben Ann, Kerkhof Melissa, Kros Johan M, Leenstra Sieger, Lombardi Giuseppe, Lukacova Slávka, Robe Pierre A, Sepulveda Juan M, Taal Walter, Taphoorn Martin, Vernhout René M, Walenkamp Annemiek M E, Watts Colin, Weller Michael, de Vos Filip Y F, Jenster Guido W, van den Bent Martin, French Pim J 5 Oct 2021, In: Neuro-Oncology. 24 , p. 429-441 13 p.

Comparison of 2-Hydroxyglutarate Detection With sLASER and MEGA-sLASER at 7T

Shams Zahra, van der Kemp Wybe J M, Emir Uzay, Dankbaar Jan Willem, Snijders Tom J, de Vos Filip Y F, Klomp Dennis W J, Wijnen Jannie P, Wiegers Evita C 7 Sep 2021, In: Frontiers in Neurology. 12 , p. 1-10

CONVENTIONAL MRI CRITERIA DIFFERENTIATE TRUE TUMOUR PROGRESSION FROM TREATMENT-INDUCED EFFECTS IN IRRADIATED WHO GRADE 3 AND 4 GLIOMAS

Flies C. M., van Leuken K. H., Verhoeff J. J. C., de Vos F. Y. F., Seute T., Robe P. A., Hendrikse J., Witkamp T. D., Dankbaar J. W., Snijders T. J. Sep 2021, In: Neuro-Oncology. 23 , p. ii41-ii41

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

Guman Noori A M, van Geffen Roos J, Mulder Frits I, van Haaps Thijs F, Hovsepjan Vahram, Labots Mariette, Cirkel Geert A, de Vos Filip Y F L, Ten Tije Albert J, Beerepoot Laurens V, Tjan-Heijnen Vivianne C G, van Laarhoven Hanneke W M, Hamberg Paul, Vulink Annelie J E, Los Maartje, Zwinderman Aeilko H, Ferwerda Bart, Lolkema Martijn P J K, Steeghs Neeltje, Büller Harry R, Kamphuisen Pieter W, van Es Nick 19 Aug 2021, In: Journal of thrombosis and haemostasis : JTH. 19 , p. 2974-2983 10 p.

Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in low‑grade (WHO grade II) gliomas

Flies Christina M, Snijders Tom J, Van Seeters Tom, Smits Marion, De Vos Filip Y F, Hendrikse Jeroen, Dankbaar Jan Willem 11 Jun 2021, In: Neuroradiology. 63 , p. 2023-2033 11 p.

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Clement Paul M J, Dirven Linda, Eoli Marica, Sepulveda-Sanchez Juan M, Walenkamp Annemiek M E, Frenel Jean S, Franceschi Enrico, Weller Michael, Chinot Olivier, De Vos Filip Y F L, Whenham Nicolas, Sanghera Paul, Looman Jim, Kundu Madan G, Peter de Geus Jan, Nuyens Sarah, Spruyt Maarten, Gorlia Thierry, Coens Corneel, Golfinopoulos Vassilis, Reijneveld Jaap C, van den Bent Martin J 15 Feb 2021, In: European Journal of Cancer. 147 , p. 1-12 12 p.

Reducing uncertainty:motivations and consequences of seeking a second opinion in oncology

Lehmann Vicky, Smets Ellen M A, de Jong Maxime, de Vos Filip Y F, Kenter Gemma G, Stouthard Jacqueline M, Hillen Marij A 1 Dec 2020, In: Acta Oncologica. 59 , p. 1512-1519 8 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet